Survival outcome and predictors of WHO grade 2 and 3 insular gliomas: A classification based on the tumor spread
- PMID: 38850123
- PMCID: PMC11161818
- DOI: 10.1002/cam4.7377
Survival outcome and predictors of WHO grade 2 and 3 insular gliomas: A classification based on the tumor spread
Abstract
Objective: The study aimed to identify if clinical features and survival outcomes of insular glioma patients are associated with our classification based on the tumor spread.
Methods: Our study included 283 consecutive patients diagnosed with histological grade 2 and 3 insular gliomas. A new classification was proposed, and tumors restricted to the paralimbic system were defined as type 1. When tumors invaded the limbic system (referred to as the hippocampus and its surrounding structures in this study) simultaneously, they were defined as type 2. Tumors with additional internal capsule involvement were defined as type 3.
Results: Tumors defined as type 3 had a higher age at diagnosis (p = 0.002) and a higher preoperative volume (p < 0.001). Furthermore, type 3 was more likely to be diagnosed as IDH wild type (p < 0.001), with a higher rate of Ki-67 index (p = 0.015) and a lower rate of gross total resection (p < 0.001). Type 1 had a slower tumor growth rate than type 2 (mean 3.3%/month vs. 19.8%/month; p < 0.001). Multivariate Cox regression analysis revealed the extent of resection (HR 0.259, p = 0.004), IDH status (HR 3.694, p = 0.012), and tumor spread type (HR = 1.874, p = 0.012) as independent predictors of overall survival (OS). Tumor grade (HR 2.609, p = 0.008), the extent of resection (HR 0.488, p = 0.038), IDH status (HR 2.225, p = 0.025), and tumor spread type (HR 1.531, p = 0.038) were significant in predicting progression-free survival (PFS).
Conclusion: The current study proposes a classification of the insular glioma according to the tumor spread. It indicates that the tumors defined as type 1 have a relatively better nature and biological characteristics, and those defined as type 3 can be more aggressive and refractory. Besides its predictive value for prognosis, the classification has potential value in formulating surgical strategies for patients with insular gliomas.
Keywords: classification; insular glioma; limbic system; oncology; paralimbic system; survival analysis.
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no relevant financial or non‐financial interests to disclose.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11161818/bin/CAM4-13-e7377-g004.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11161818/bin/CAM4-13-e7377-g001.gif)
![FIGURE 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11161818/bin/CAM4-13-e7377-g002.gif)
![FIGURE 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11161818/bin/CAM4-13-e7377-g003.gif)
Similar articles
-
Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Int J Clin Oncol. 2020 Jun;25(6):1004-1009. doi: 10.1007/s10147-020-01628-7. Epub 2020 Feb 4. Int J Clin Oncol. 2020. PMID: 32020379 Review.
-
Transcortical insular glioma resection: clinical outcome and predictors.J Neurosurg. 2018 Oct 19;131(3):706-716. doi: 10.3171/2018.4.JNS18424. J Neurosurg. 2018. PMID: 30485243
-
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.Crit Rev Oncol Hematol. 2017 Dec;120:1-9. doi: 10.1016/j.critrevonc.2017.09.013. Epub 2017 Oct 3. Crit Rev Oncol Hematol. 2017. PMID: 29198322 Review.
-
Putamen involvement and survival outcomes in patients with insular low-grade gliomas.J Neurosurg. 2017 Jun;126(6):1788-1794. doi: 10.3171/2016.5.JNS1685. Epub 2016 Aug 26. J Neurosurg. 2017. PMID: 27564467
-
Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.J Neurooncol. 2016 Feb;126(3):499-507. doi: 10.1007/s11060-015-1989-5. Epub 2015 Nov 19. J Neurooncol. 2016. PMID: 26586262
References
-
- Tramo MJ, Loftus WC, Thomas CE, Green RL, Mott LA, Gazzaniga MS. Surface area of human cerebral cortex and its gross morphological subdivisions: in vivo measurements in monozygotic twins suggest differential hemisphere effects of genetic factors. J Cogn Neurosci. 1995;7(2):292‐302. Epub 1995/04/01. doi:10.1162/jocn.1995.7.2.292 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical